Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cimdelirsen - Ionis Pharmaceuticals

Next Previous
X
Search
Drug Profile

Cimdelirsen - Ionis Pharmaceuticals

Alternative Names: Cimdelirsen sodium; IONIS GHR LRx; IONIS-GHR-LRX; ISIS 766720; ISIS 766720, sodiated

Latest Information Update: 16 Jun 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ionis Pharmaceuticals
  • Class Antisense oligonucleotides
  • Mechanism of Action Somatotropin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acromegaly

Most Recent Events

  • 04 May 2023 Ionis Pharmaceuticals completes a phase II clinical trial in Acromegaly (Monotherapy, Adjuvant therapy, Treatment-naive) in Hungary, Estonia, Latvia, Lithuania, Italy, Poland, Romania, Russia, Serbia, USA (SC) (NCT04522180)
  • 03 May 2023 Discontinued - Phase-II for Acromegaly (Adjunctive treatment, In the elderly, In adults) in Hungary, Lithuania, USA (SC)
  • 03 May 2023 Discontinued - Phase-II for Acromegaly (Adjunctive treatment, In the elderly, In adults) in Serbia, Russia, Romania, Poland, Czech Republic, Austria (SC)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top